This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity
Clinical trial NCT06857617 · COMPLETED
Trial details
- NCT number
- NCT06857617
- Sponsor
- Metsera, a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-01-03
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.